• Search

Search in Site

Industry news and analysis across pharma and medical devices PharmaDeviceNews.com

  • Home
  • Pharma & Biotech
  • Medical Devices & Diagnostics
  • Features & Analysis
  • Privacy Policy
  • About PharmaDeviceNews
  • Editorial Policy
  • Disclaimer
  • Contact Us
Home»Posts tagged with»digital therapeutics

Why the Syra Health and Nora Mental Health deal matters for telebehavioral care in Indiana

By Pallavi Madhiraju on April 3, 2026   Pharma & Biotech  

Why the Syra Health and Nora Mental Health deal matters for telebehavioral care in Indiana

Syra Health and Nora Mental Health are linking AI triage with teletherapy in Indiana. Read why this could reshape digital mental health access.

How DarioHealth aims to strengthen oral GLP-1 effectiveness through precision behavioral health tools

By Pallavi Madhiraju on March 8, 2026   Pharma & Biotech  

How DarioHealth aims to strengthen oral GLP-1 effectiveness through precision behavioral health tools

DarioHealth targets oral GLP-1 therapy support with behavioral digital tools. Discover how digital health platforms could reshape obesity and diabetes treatment.

Can smart dental devices redefine sleep disorder treatment? Aesyra’s trial says yes

By Pallavi Madhiraju on January 26, 2026   Medical Devices & Diagnostics  

Can smart dental devices redefine sleep disorder treatment? Aesyra’s trial says yes

Aesyra’s AesyBite Active reduced sleep bruxism by over 60% in trial. Find out what this could mean for digital therapeutics and FDA approval in 2026.

Brello Rise enters the obesity care landscape as a digital wellness adjunct to medical weight loss

By Pallavi Madhiraju on January 26, 2026   Pharma & Biotech  

Brello Rise enters the obesity care landscape as a digital wellness adjunct to medical weight loss

Brello Health launches Brello Rise, a digital studio for patients in medical weight loss programs. Find out what this signals for obesity care models.

Recent Posts

  • AACR 2026: SAGA Diagnostics pushes Pathlight MRD deeper into metastatic breast and ovarian cancer
  • Agenus AACR 2026 data show immune reprogramming signal in PD-1 refractory gastroesophageal cancer
  • AACR 2026: Can Zai Lab’s zocilurtatug pelitecan change the treatment picture for small cell lung cancer brain metastases?
  • How JANX014 expands Janux Therapeutics’ tumor-activated platform strategy in prostate cancer immunotherapy
  • What Medicus Pharma Ltd.’s SkinJect application signals for Hedgehog pathway-driven cancers
  • Why Bioxodes’ adaptive trial strategy could accelerate approval timelines in stroke therapeutics
  • What Kura Oncology’s latest data reveals about resistance biology in kidney cancer
  • Can Fate Therapeutics, Inc. solve the conditioning chemotherapy problem in CAR T?
  • Could Ampligen become a late-stage pancreatic cancer breakthrough after AIM ImmunoTech’s latest clinical push?
  • What the new J-code means for Glaukos’ Epioxa launch and the future of keratoconus reimbursement
  • Molgramostim review pushed to November: what Savara’s FDA delay means for autoimmune PAP
  • What SurGenTec’s TiLink navigation clearance means for surgeons using minimally invasive SI joint fusion systems
    • About PharmaDeviceNews
    • Contact Us
    • Disclaimer
    • Editorial Policy
    • Privacy Policy
© 2026, ↑ PharmaDeviceNews
Log in - Powered by WordPress - Gabfire Themes